Targets › CTXB
1 program from 1 company in 1 trial: 1 Phase 1; Vaccines; next expected readout Nov 2026.
Open in Phaseline: the race on CTXB, likelihood bands and readouts
| Company | Drug | Targets | Highest phase | Conditions | Next expected readout |
|---|---|---|---|---|---|
| Centre for Infectious Disease Research in Zambia | PanChol Live attenuated oral cholera vaccine with El Tor background and genetic modifications to r | CTXB | Phase 1 | Cholera Vaccination Reaction | Nov 2026 |
Cholera Vaccination Reaction (1)
protein or peptide (1)
Centre for Infectious Disease Research in Zambia (1)
–
Programs group each company's trials by drug; targets and mechanisms come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood is in the app.